உருவகப்படுத்துதல்கள் ப்லஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உருவகப்படுத்துதல்கள் ப்லஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உருவகப்படுத்துதல்கள் ப்லஸ் Today - Breaking & Trending Today

Chinese Drug Agency Licenses Simulations Plus Software | San Fernando Valley Business Journal

Simulations Plus Inc. received an order from China’s drug evaluation agency to license its GastroPlus product.
Financial terms of the deal between the Lancaster drug modeling software developer and the Center for Drug Evaluation of the National Medical Products Administration in China were not disclosed.
John DiBella, Simulations Plus division president said, the company has cultivated relationships with different institutions affiliated with China’s National Medical Products Administration to use its technology for the evaluation of drug specifications and bioequivalence.
“Now, researchers at the CDE will add GastroPlus to serve as a key platform for model-informed drug development to aid regulatory reviews,” DiBella said in a statement. “This news is welcomed by over 20 (and growing) domestic Chinese pharmaceutical companies and research hospitals that have been employing our technologies.” ....

Mark Madler , John Dibella , China National Medical Products Administration , Chinese Drug Agency Licenses Simulations Plus Software , Simulations Plus Inc , Chinese Drug Agency Licenses Simulations Plus , Drug Evaluation , National Medical Products Administration , Simulations Plus , ஜான் டிபெல்லா , உருவகப்படுத்துதல்கள் ப்லஸ் இன்க் , மருந்து மதிப்பீடு , உருவகப்படுத்துதல்கள் ப்லஸ் ,

Simulations Plus: Das sollte man sich durch den Kopf gehen lassen … ()

04.08.21 01:59
Aktiennews
Der Kurs der Aktie Simulations Plus steht am 04.08.2021, 01:59 Uhr an der heimatlichen Börse NASDAQ GS bei 46.94 USD. Der Titel wird der Branche Gesundheitstechnologie zugerechnet.
Unser Analystenteam hat Simulations Plus auf Basis dieser Bewertung am Markt einer Analyse zugeführt. Insgesamt 8 Faktoren führen zu den einzelnen Einschätzungen als Buy , Hold oder Sell . Daraus wird im letzten Schritt eine Gesamteinschätzung ermittelt.
1. Fundamental: Das aktuelle Kurs-Gewinn-Verhältnis (KGV) von Simulations Plus liegt bei einem Wert von 84,07. Die Aktie liegt damit im Vergleich zu Werten aus der Branche Gesundheitstechnologie (KGV von 72,52) über dem Durschschnitt (ca. 16 Prozent). Aus Sicht fundamentaler Kriterien ist Simulations Plus damit überbewertet und erhält folglich eine Sell -Bewertung auf dieser Stufe. ....

Share Simulations , Simulations Plus , Last Step , Change For , Relative Strength , Now For , Should Investors , Corona Krise Continue , Oday News , உருவகப்படுத்துதல்கள் ப்லஸ் , கடந்த படி , மாற்றம் க்கு , உறவினர் வலிமை , இப்போது க்கு , வேண்டும் முதலீட்டாளர்கள் , நாள் செய்தி ,

Hedge Funds Aren't Crazy About Kiniksa Pharmaceuticals, Ltd. (KNSA) Anymore

Hedge Funds Aren't Crazy About Kiniksa Pharmaceuticals, Ltd. (KNSA) Anymore
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Felix Baker , Jim Cramer , Didric Cederholm , Bhagwan Jay Rao , Julian Baker , Sander Gerber Hudson , Ken Griffin Citadel Investment Group , Encore Capital Group Inc , Designer Brands Inc , Simulations Plus Inc , Kiniksa Pharmaceuticals Ltd , Stride Inc , Safety Insurance Group Inc , Health Asset Management , Vocera Communications Inc , Matthews International Corp , Melvin Capital , Kiniksa Pharmaceuticals , Cederholm Lion Point Capital , Lion Point , Insider Monkey , Good Stock To Buy , Lei Zhang , Hillhouse Capital Management , Ken Griffin , Citadel Investment Group ,

Where Do Hedge Funds Stand On Vocera Communications Inc (VCRA)?

Where Do Hedge Funds Stand On Vocera Communications Inc (VCRA)?
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Jim Cramer , Amos Meron , John Overdeck , Ken Griffin Citadel Investment Group , Encore Capital Group Inc , Designer Brands Inc , Simulations Plus Inc , Kosmos Energy Ltd , Exchange Commission , Stride Inc , Safety Insurance Group Inc , Vocera Communications Inc , Matthews International Corp , Insider Monkey , Simulations Plus , Encore Capital Group , Designer Brands , Two Sigma , Good Stock To Buy , Renaissance Technologies , Street Capital , Two Sigma Advisors , Intrinsic Edge Capital , Partners Management , Ken Griffin , Citadel Investment Group ,

Analyzing Simulations Plus's Ex-Dividend Date

Analyzing Simulations Plus's Ex-Dividend Date
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Simulations Plus , உருவகப்படுத்துதல்கள் ப்லஸ் ,